HDL biology
CETP expression preserves endothelial function in female mice via enhanced estrogen receptor-alpha and eNOS signaling, unlike its harmful effect in males (Am J Physiol Heart Circ Physiol 2023)
Original title: CETP expression ameliorates endothelial function in female mice through estrogen receptor-α and endothelial nitric oxide synthase pathway
Contrasting with prior findings that male mice expressing human CETP show impaired endothelium-mediated vascular relaxation, aortas from female CETP-transgenic mice preserved endothelium-dependent relaxation to acetylcholine and reduced phenylephrine-induced contraction compared with nontransgenic controls. CETP females showed enhanced eNOS phosphorylation (Ser1177) and calcium-induced nitric oxide levels, alongside reduced reactive oxygen species production and NOX2 and SOD2 expression. CETP females also exhibited increased aortic relaxation to 17beta-estradiol and upregulation of heat shock protein 90 and caveolin-1, proteins that stabilize estrogen receptor in caveolae; this estradiol-induced relaxation was sensitive to estrogen receptor-alpha and heat shock protein 90 inhibitors, and the estrogen receptor-alpha inhibitor also impaired acetylcholine-induced relaxation in CETP but not nontransgenic females. These results indicate CETP expression has sex-specific, beneficial vascular effects in females.
Original abstract
Endothelial dysfunction is an early manifestation of atherosclerosis. The cholesteryl ester transfer protein (CETP) has been considered proatherogenic by reducing plasma HDL levels. However, CETP may exhibit cell- or tissue-specific effects. We have previously reported that male mice expressing the human CETP gene show impaired endothelium-mediated vascular relaxation associated with oxidative stress. Although sexual dimorphisms on the metabolic role of CETP have been proposed, possible sex differences in the vascular effects of CETP were not previously studied. Thus, here we investigated the endothelial function of female CETP transgenic mice as compared with nontransgenic controls (NTg). Aortas from CETP females presented preserved endothelium-dependent relaxation to acetylcholine and an endothelium-dependent reduction of phenylephrine-induced contraction. eNOS phosphorylation (Ser1177) and calcium-induced NO levels were enhanced, whereas reactive oxygen species (ROS) production and NOX2 and SOD2 expression were reduced in the CETP female aortas. Furthermore, CETP females exhibited increased aortic relaxation to 17β-estradiol (E2) and upregulation of heat shock protein 90 (HSP90) and caveolin-1, proteins that stabilize estrogen receptor (ER) in the caveolae. Indeed, CETP females showed an increased E2-induced relaxation in a manner sensitive to estrogen receptor-α (ERα) and HSP90 inhibitors methylpiperidinopyrazole (MPP) and geldanamycin, respectively. MPP also impaired the relaxation response to acetylcholine in CETP but not in NTg females. Altogether, the study indicates that CETP expression ameliorates the anticontractile endothelial effect and relaxation to E2 in females. This was associated with less ROS production, and increased eNOS-NO and E2-ERα pathways. These results highlight the need for considering the sex-specific effects of CETP on cardiovascular risk.NEW & NOTEWORTHY Here we demonstrated that CETP expression has a sex-specific impact on the endothelium function. Contrary to what was described for males, CETP-expressing females present preserved endothelium-dependent relaxation to acetylcholine and improved relaxation response to 17β-estradiol. This was associated with less ROS production, increased eNOS-derived NO, and increased expression of proteins that stabilize estrogen receptor-α (ERα), thus increasing E2-ERα signaling sensitivity. These results highlight the need for considering the sex-specific effects of CETP on cardiovascular risk.
Summary written by cetpinhibition.org from the published abstract; figures as published. Page updated 19 August 2026. Methods.